These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2891821)
21. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase. Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672 [TBL] [Abstract][Full Text] [Related]
22. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Kuhlencord A; Maniera T; Eibl H; Unger C Antimicrob Agents Chemother; 1992 Aug; 36(8):1630-4. PubMed ID: 1329624 [TBL] [Abstract][Full Text] [Related]
23. Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection. Mittal N; Gupta N; Goyal N; Singh AK; Guru PY; Pandey VC; Rastogi AK Indian J Exp Biol; 1997 Apr; 35(4):393-6. PubMed ID: 9315242 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice. Pal S; Ravindran R; Ali N Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135 [TBL] [Abstract][Full Text] [Related]
25. The sensitivity of Leishmania species to aminosidine. Neal RA; Allen S; McCoy N; Olliaro P; Croft SL J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170 [TBL] [Abstract][Full Text] [Related]
26. Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations. Banduwardene R; Mullen AB; Carter KC Int J Immunopharmacol; 1997 Apr; 19(4):195-203. PubMed ID: 9373770 [TBL] [Abstract][Full Text] [Related]
27. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody. Nabors GS; Farrell JP Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533 [TBL] [Abstract][Full Text] [Related]
28. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice. Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361 [TBL] [Abstract][Full Text] [Related]
29. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection. Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162 [TBL] [Abstract][Full Text] [Related]
30. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report. Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588 [No Abstract] [Full Text] [Related]
31. Antileishmanial activity of antimonials entrapped in liposomes. New RR; Chance ML; Thomas SC; Peters W Nature; 1978 Mar; 272(5648):55-6. PubMed ID: 203863 [No Abstract] [Full Text] [Related]
32. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Escobar P; Yardley V; Croft SL Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640 [TBL] [Abstract][Full Text] [Related]
33. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365 [TBL] [Abstract][Full Text] [Related]
34. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice. Joshi J; Kaur S Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257 [TBL] [Abstract][Full Text] [Related]
35. Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. Murray HW J Infect Dis; 1990 May; 161(5):992-4. PubMed ID: 2157773 [TBL] [Abstract][Full Text] [Related]
36. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728 [TBL] [Abstract][Full Text] [Related]
37. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate. Chulay JD; Fawcett DW; Chunge CN Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304 [TBL] [Abstract][Full Text] [Related]
38. Action of p-(4-amidino-phenoxy)-benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster. Raether W; Seidenath H; Loewe H Ann Trop Med Parasitol; 1978 Dec; 72(6):543-7. PubMed ID: 216324 [TBL] [Abstract][Full Text] [Related]
39. An experimental model system for leishmaniasis. An ultrastructural study on cultured macrophages exposed to Leishmania parasites and sodium stibogluconate. Abok K; Fredriksson BA; Brunk U APMIS; 1988 Jul; 96(7):589-95. PubMed ID: 2841954 [TBL] [Abstract][Full Text] [Related]
40. Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. Baumann RJ; Hanson WL; McCann PP; Sjoerdsma A; Bitonti AJ Antimicrob Agents Chemother; 1990 May; 34(5):722-7. PubMed ID: 2360812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]